Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
External Tibetan Medicine for Motor Pain After Knee Arthroplasty
ChiCTR2500113830Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Qizheng Xiaotong Plaster, qingpeng ointment, Baimai and celecoxib in postoperative pain (4 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Visual Analog Scale (VAS) score after knee flexion-extension exercise. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Qizheng Xiaotong Plasterqingpeng ointmentBaimaicelecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500113830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113830.